• Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain

    8 days ago - By San Diego Biotechnology

    SAN DIEGO, Dec. 3, 2019 /PRNewswire/ - Heron Therapeutics, Inc. , a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet p......
    Read more ...

     

  • DelMar Pharmaceuticals to Present at the LD Micro 12th Annual Main Event on December 10, 2019

    8 days ago - By San Diego Biotechnology

    SAN DIEGO, Dec. 3, 2019 /PRNewswire/ - DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that Mr. Saiid Zarrabian, Chief E......
    Read more ...